Holen Sie sich die Stockscreener-App
4.86
25.91%
1.00
Vorhandelsmarkt:
4.94
0.08
+1.65%
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Perspective Therapeutics Inc. stock momentum explainedPortfolio Value Summary & High Yield Stock Recommendations - newser.com
Applying Wyckoff theory to Perspective Therapeutics Inc. stockInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Can Perspective Therapeutics Inc. recover in the next quarter2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Will Perspective Therapeutics Inc. stock go up soonWeekly Trade Report & Precise Swing Trade Entry Alerts - newser.com
Is Perspective Therapeutics Inc. stock a smart buy before Fed meetingDollar Strength & Daily Profit Focused Screening - newser.com
Candlestick signals on Perspective Therapeutics Inc. stock todayPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Using Bollinger Bands to evaluate Perspective Therapeutics Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Can Perspective Therapeutics Inc. rally from current levelsJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Has Perspective Therapeutics Inc. found a price floor2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Will Perspective Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating By Investing.com - Investing.com Nigeria
BTIG Initiates Coverage of Perspective Therapeutics (CATX) with Buy Recommendation - Nasdaq
BTIG initiates coverage on Perspective Therapeutics stock with Buy rating - Investing.com
BTIG Research Initiates Coverage on Perspective Therapeutics With Buy Rating, $14 Price Target - MarketScreener
BTIG Initiates Coverage on CATX with a Buy Rating and $14 Target - GuruFocus
Technical analysis overview for Perspective Therapeutics Inc. stock - newser.com
Will Perspective Therapeutics Inc. stock outperform small cap peers2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Real time social sentiment graph for Perspective Therapeutics Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
How robust is Perspective Therapeutics Inc. stock financial positionJuly 2025 Decliners & Verified Momentum Stock Ideas - newser.com
Why Perspective Therapeutics Inc. (AAJ0) stock stays undervaluedTrade Signal Summary & Long-Term Safe Investment Plans - newser.com
How dovish Fed policy supports Perspective Therapeutics Inc. (AAJ0) stock2025 Technical Overview & Risk Adjusted Buy/Sell Alerts - newser.com
Will Perspective Therapeutics Inc. rebound enough to break evenWeekly Gains Summary & High Conviction Trade Alerts - newser.com
Volatility clustering patterns for Perspective Therapeutics Inc.Portfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
Top chart patterns to watch in Perspective Therapeutics Inc.2025 Market Trends & Verified Entry Point Signals - newser.com
Perspective Therapeutics Inc. stock outlook for YEARMarket Trend Summary & Daily Technical Forecast Reports - newser.com
Can Perspective Therapeutics Inc. stock reach $200 price target2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Analyzing Perspective Therapeutics Inc. with risk reward ratio charts2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Applying Elliott Wave Theory to Perspective Therapeutics Inc.Gap Up & Free Fast Entry Momentum Trade Alerts - newser.com
What drives Perspective Therapeutics Inc AAJ0 stock priceMoving Average Crossovers & Free Record-Breaking Gains - earlytimes.in
Perspective Therapeutics, Inc. Common Stock (NYSE:CATX) Stock Quote - FinancialContent
How Perspective Therapeutics Inc. (AAJ0) stock valuation compares with sectorMarket Activity Report & Safe Entry Momentum Tips - newser.com
Heatmap analysis for Perspective Therapeutics Inc. and competitorsTrend Reversal & Safe Entry Momentum Tips - newser.com
Is Perspective Therapeutics Inc. (AAJ0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - newser.com
Is Perspective Therapeutics Inc. stock attractive for retirement portfoliosWeekly Stock Recap & Consistent Growth Equity Picks - newser.com
What earnings revisions data tells us about Perspective Therapeutics Inc.July 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
Perspective Therapeutics (NYSE:CATX) Receives Outperform Rating from Wedbush - Defense World
Perspective Therapeutics (NYSE:CATX) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reiterates Buy Rating for Perspective Therapeutics (NYSE:CATX) - MarketBeat
CATX: HC Wainwright & Co. Reiterates Buy Rating with $10 Target - GuruFocus
HC Wainwright & Co. Reiterates Perspective Therapeutics (CATX) Buy Recommendation - Nasdaq
H.C. Wainwright reiterates Buy rating on Perspective Therapeutics stock - Investing.com
Why Perspective Therapeutics Inc. (AAJ0) stock is favored by hedge fundsEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
Is Perspective Therapeutics Inc. stock ready for a breakoutMarket Activity Summary & AI Driven Stock Price Forecasts - newser.com
Perspective Therapeutics Announces First Patient Dosed with - GlobeNewswire
Can Perspective Therapeutics Inc. stock sustain margin levelsWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
1.83%
Kapitalisierung:
|
Volumen (24h):